Details for New Drug Application (NDA): 077155
✉ Email this page to a colleague
NDA 077155 describes FENOLDOPAM MESYLATE, which is a drug marketed by Hikma, Luitpold, Sandoz, and Teva Parenteral, and is included in four NDAs. Additional details are available on the FENOLDOPAM MESYLATE profile page.
The generic ingredient in FENOLDOPAM MESYLATE is fenoldopam mesylate. There are five drug master file entries for this compound. Additional details are available on the fenoldopam mesylate profile page.
The generic ingredient in FENOLDOPAM MESYLATE is fenoldopam mesylate. There are five drug master file entries for this compound. Additional details are available on the fenoldopam mesylate profile page.
Summary for 077155
| Tradename: | FENOLDOPAM MESYLATE |
| Applicant: | Sandoz |
| Ingredient: | fenoldopam mesylate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 077155
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 10MG BASE/ML | ||||
| Approval Date: | Feb 15, 2005 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
